Stockscreener 앱 받기
1.29
18.35%
0.20
시장 영업 전:
1.29
Renovorx Inc 주식(RNXT)의 최신 뉴스
What does recent volatility data suggest for RenovoRx Inc.Market Trend Summary & High Accuracy Swing Trade Signals - newser.com
Has RenovoRx Inc. formed a bullish divergenceQuarterly Investment Review & Reliable Breakout Forecasts - newser.com
Evaluating RenovoRx Inc. with trendline analysisPortfolio Return Report & Long-Term Safe Investment Ideas - newser.com
Relative strength of RenovoRx Inc. in sector analysisQuarterly Growth Report & AI Forecast for Swing Trade Picks - newser.com
Is RenovoRx Inc. stock reversal real or fakeJuly 2025 Retail & AI Enhanced Trade Execution Alerts - newser.com
RenovoRx : Expands Scientific Advisory Board with Internationally Renowned Interventional Oncologist, Thierry de Baère, MD, PhD - MarketScreener
Is RenovoRx Inc. stock entering bullish territory2025 Stock Rankings & Community Trade Idea Sharing Platform - newser.com
Is RenovoRx Inc. reversing from oversold territoryJuly 2025 Snapshot & Free High Accuracy Swing Entry Alerts - newser.com
Identifying reversal signals in RenovoRx Inc.Weekly Investment Report & Free Growth Oriented Trading Recommendations - newser.com
RenovoRx Inc. stock chart pattern explainedMarket Weekly Review & Step-by-Step Trade Execution Guides - newser.com
Is RenovoRx Inc. forming a bottoming baseEarnings Growth Summary & Weekly Chart Analysis and Guides - newser.com
Will RenovoRx Inc. stock outperform Dow Jones indexAnalyst Upgrade & Risk Controlled Daily Trade Plans - newser.com
RenovoRx adds interventional oncology expert to scientific advisory board By Investing.com - Investing.com Nigeria
RenovoRx’s Earnings Call: Positive Outlook Amid Growth - MSN
RenovoRx adds interventional oncology expert to scientific advisory board - Investing.com
RenovoRx expands Scientific Advisory Board with appointment of Baere - TipRanks
RenovoRx Appoints Renowned Oncologist Thierry de Baère, MD, PhD, to Scientific Advisory Board - Quiver Quantitative
400+ publications & 22,000 citations: RenovoRx appoints Thierry de Baère to Scientific Advisory Board - Stock Titan
Will RenovoRx Inc. outperform the marketMarket Weekly Review & Intraday High Probability Setup Alerts - newser.com
Will earnings trigger a reversal in RenovoRx Inc.Buy Signal & Free Weekly Chart Analysis and Trade Guides - newser.com
Forecasting RenovoRx Inc. price range with options data2025 Investor Takeaways & Weekly Momentum Picks - newser.com
RenovoRx : Corporate Overview - MarketScreener
Custom strategy builders for tracking RenovoRx Inc.2025 Earnings Impact & Low Volatility Stock Recommendations - newser.com
Developing predictive dashboards with RenovoRx Inc. dataEarnings Overview Report & Long-Term Growth Portfolio Plans - newser.com
How institutional ownership impacts RenovoRx Inc. stock2025 Short Interest & Fast Gaining Stock Reports - newser.com
RenovoRx prices public offering to raise $12.1M - MSN
Comparing Annovis Bio (NYSE:ANVS) & RenovoRx (NASDAQ:RNXT) - Defense World
RenovoRx (NASDAQ:RNXT) Trading Up 7.6% – Here’s What Happened - Defense World
What analysts say about RenovoRx Inc stockCurrency Fluctuation Impact & Register for the Next Free Workshop - earlytimes.in
RenovoRx Inc Stock Analysis and ForecastTechnical Pattern Recognition & Budget Friendly Portfolio Growth - earlytimes.in
4.09%
0.09%
자본화:
|
볼륨(24시간):